糖蛋白特异性转录反应有助于对致命的埃博拉病毒感染进行差异性疫苗保护
Sheridan B Wagner1, Delphine C Malherbe1, Ethan G Napier1
1Department of Microbiology, Immunology, and Molecular Genetics, College of Medicine, University of Kentucky, Lexington, KY, United States of America.
Vaccine
|March 12, 2026
概括
埃博拉疫苗VSV-Kik提供快速保护和强烈的免疫反应,而VSV-Mak疫苗只提供部分保护,转录变化最小,突出了糖蛋白特异性疫苗的疗效.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 再次爆发的埃博拉病毒疫情需要有效的疫苗接种策略,正如2014-2016年西非流行病后所见的那样.
- 美国食品和药物管理局批准的VSV-Kik疫苗 (ERVEBO) 提供了对埃博拉病毒 (EBOV) - Makona的快速保护,在最近的疫情中使用的剂量减少.
- 了解低剂量疫苗的疗效和转录反应对于优化疫苗供应和疫情期间的覆盖率至关重要.
研究的目的:
- 为了比较低剂量VSV-Mak和VSV-Kik疫苗诱导的转录反应.
- 评估这些疫苗对EBOV-Makona疫苗的保护疗效的挑战.
- 在 EBOV 变种同源性背景下调查糖蛋白特异性免疫反应.
主要方法:
- 小鼠接种了低剂量 (1 × 10^4 PFU) 的实验室级VSV-Mak或GMP级VSV-Kik.
- 接种疫苗的小鼠在接种疫苗后10天接受了EBOV-Makona的挑战.
- 分析了接种疫苗和挑战小鼠的转录反应.
主要成果:
- VSV-Kik 提供了对异种 EBOV-Makona 挑战的完整保护.
- VSV-Kik引发了快速的抗病毒转录变化和随后的自适应性免疫激活.
- VSV-Mak只提供了部分保护,并诱导了最小的转录反应.
结论:
- 与VSV-Mak.Kik相比,VSV-Kik表现出更高的疗效,并诱导出更强大的转录反应.
- 疫苗诱导的转录反应是针对病毒葡萄糖蛋白的特异性,即使在密切相关的EBOV变体中也是如此.
- 这些发现强调了糖蛋白选择在疫苗设计中的重要性,以有效控制EBOV.
更多相关视频
10:11Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
37.1K
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
2.3K
相关概念视频
00:42Cross-reactivity
33.7K
Overview
33.7K
02:28Leaky Scanning
5.8K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.8K
01:29Immune Response Against Viral Pathogens
2.4K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K